BLAC Annual ROE
1.24%
-93.16%-98.69%
01 December 2023
Summary:
As of February 3, 2025, BLAC annual return on equity is 1.24%, with the most recent change of -93.16% (-98.69%) on December 1, 2023. BLAC annual ROE is now -99.21% below its all-time high of 157.14%, reached on December 1, 2021.BLAC ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BLAC Quarterly ROE
-2.00%
-1.56%-354.55%
01 September 2024
Summary:
As of February 3, 2025, BLAC quarterly return on equity is -2.00%, with the most recent change of -1.56% (-354.55%) on September 1, 2024. Over the past year, it has stayed the same.BLAC quarterly ROE is now -100.89% below its all-time high of 224.48%, reached on September 1, 2022.BLAC Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BLAC ROE Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -98.7% | 0.0% |
3 y3 years | - | 0.0% |
5 y5 years | - | 0.0% |
BLAC ROE High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -99.2% | at low | -100.9% | at low |
5 y | 5-year | -99.2% | at low | -100.9% | at low |
alltime | all time | -99.2% | at low | -100.9% | at low |
Bellevue Life Sciences Acquisition ROE History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | -2.00%(+354.5%) |
June 2024 | - | -0.44%(-195.7%) |
Mar 2024 | - | 0.46%(-32.4%) |
Dec 2023 | 1.24% | 0.68%(-26.1%) |
Sept 2023 | - | 0.92%(-16.4%) |
June 2023 | - | 1.10%(+150.0%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2023 | - | 0.44%(-99.7%) |
Dec 2022 | 94.40%(-39.9%) | 165.94%(-26.1%) |
Sept 2022 | - | 224.48%(+296.6%) |
June 2022 | - | 56.60%(-62.9%) |
Mar 2022 | - | 152.38%(+3.2%) |
Dec 2021 | 157.14% | 147.62% |
FAQ
- What is Bellevue Life Sciences Acquisition annual return on equity?
- What is the all time high annual ROE for Bellevue Life Sciences Acquisition?
- What is Bellevue Life Sciences Acquisition annual ROE year-on-year change?
- What is Bellevue Life Sciences Acquisition quarterly return on equity?
- What is the all time high quarterly ROE for Bellevue Life Sciences Acquisition?
- What is Bellevue Life Sciences Acquisition quarterly ROE year-on-year change?
What is Bellevue Life Sciences Acquisition annual return on equity?
The current annual ROE of BLAC is 1.24%
What is the all time high annual ROE for Bellevue Life Sciences Acquisition?
Bellevue Life Sciences Acquisition all-time high annual return on equity is 157.14%
What is Bellevue Life Sciences Acquisition annual ROE year-on-year change?
Over the past year, BLAC annual return on equity has changed by -93.16% (-98.69%)
What is Bellevue Life Sciences Acquisition quarterly return on equity?
The current quarterly ROE of BLAC is -2.00%
What is the all time high quarterly ROE for Bellevue Life Sciences Acquisition?
Bellevue Life Sciences Acquisition all-time high quarterly return on equity is 224.48%
What is Bellevue Life Sciences Acquisition quarterly ROE year-on-year change?
Over the past year, BLAC quarterly return on equity has changed by 0.00% (0.00%)